Researchers from Department of Orthopedics Report Recent Findings in Alcoholism (Theorizing The Role of Gama Type Endorphins in Schizophrenia and Alcoholism: Promoting Genetic Testing and Attempts at Inducing "Dopamine Homeostasis.").

The article focuses on research examining the relationship between substance use disorder (SUD) and schizophrenia, particularly through the lens of dopaminergic neurotransmission and genetic predispositions within the framework of Reward Deficiency Syndrome (RDS). The study suggests that a deficiency in gamma-type endorphins may lead to increased dopaminergic activity, exacerbating symptoms of schizophrenia. It also proposes that specific genetic alleles, such as the DRD2 Taq1 A2 allele, could influence susceptibility to SUD in individuals with schizophrenia. The research highlights the need for further studies, including neuroimaging and genetic analyses, to better understand the connections between these disorders and to develop targeted interventions. [Extracted from the article]